Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Immunome Q3 EPS $(0.36) Up From $(0.75) YoY, Sales $3.56M

Author: Benzinga Newsdesk | November 09, 2023 09:21am
Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.36) per share. This is a 52 percent increase over losses of $(0.75) per share from the same period last year. The company reported $3.56 million in sales this quarter.

Posted In: IMNM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist